{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:51:34Z","timestamp":1789919494708,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.yexmp.2011.04.006","type":"journal-article","created":{"date-parts":[[2011,4,24]],"date-time":"2011-04-24T17:55:01Z","timestamp":1303667701000},"page":"335-345","source":"Crossref","is-referenced-by-count":24,"title":["C5b-9-activated, Kv1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation"],"prefix":"10.1016","volume":"91","author":[{"given":"Cosmin A.","family":"Tegla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Cudrici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Rozycka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Soloviova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Azimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Andrian-Albescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anver","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Niculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan I.V.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horea","family":"Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2011.04.006_bb0005","doi-asserted-by":"crossref","first-page":"8234","DOI":"10.1523\/JNEUROSCI.17-21-08234.1997","article-title":"Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells","volume":"17","author":"Attali","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/glia.20067","article-title":"K+ channel blockade impairs remyelination in the cuprizone model","volume":"48","author":"Bacia","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0020","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1083\/jcb.147.6.1123","article-title":"Axonal control of oligodendrocyte development","volume":"147","author":"Barres","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0025","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1517\/13543780903002082","article-title":"Sustained-release fampridine for multiple sclerosis","volume":"18","author":"Bever","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0030","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1093\/emboj\/cdf662","article-title":"Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TR{alpha}1)","volume":"21","author":"Billon","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","article-title":"Homogeneity of active demyelinating lesions in established multiple sclerosis","volume":"63","author":"Breij","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0040","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.134.3.1804","article-title":"Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9","volume":"134","author":"Carney","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0045","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1073\/pnas.042698399","article-title":"Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1\/S phase progression of the cell cycle","volume":"99","author":"Chittajallu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuroscience.2006.09.055","article-title":"Neurotrophin B receptor kinase increases Kv subfamily member 1.3 (Kv1.3) ion channel half-life and surface expression","volume":"144","author":"Colley","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2990.1989.tb01231.x","article-title":"Immunocytochemical localization of the terminal complement complex in multiple sclerosis","volume":"15","author":"Compston","year":"1989","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.cdd.4400627","article-title":"Complement mediated cell death is associated with DNA fragmentation","volume":"7","author":"Cragg","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0065","first-page":"A324","article-title":"C5b-9 protects oligodendrocytes apoptosis by regulating BH-3-only proapoptotic proteins","volume":"19","author":"Cudrici","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0070","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.4049\/jimmunol.176.5.3173","article-title":"C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP","volume":"176","author":"Cudrici","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2008.06.040","article-title":"Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis","volume":"203","author":"Cudrici","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0080","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0085","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.02-0802fje","article-title":"The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism","volume":"17","author":"El-Kholy","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yexmp.2008.12.005","article-title":"Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells","volume":"86","author":"Fosbrink","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0095","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1523\/JNEUROSCI.19-13-05380.1999","article-title":"Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells","volume":"19","author":"Ghiani","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","article-title":"Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial","volume":"373","author":"Goodman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0105","doi-asserted-by":"crossref","first-page":"C257","DOI":"10.1152\/ajpcell.00010.2005","article-title":"Insulin-activated, K+\u2212channel-sensitive Akt pathway is primary mediator of ML-1 cell proliferation","volume":"289","author":"Guo","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00308961","article-title":"Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis","volume":"79","author":"Linington","year":"1989","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q","article-title":"The membrane attack complex of complement induces caspase activation and apoptosis","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0125","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.4049\/jimmunol.158.9.4405","article-title":"Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent","volume":"158","author":"Niculescu","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0021-9150(98)00185-3","article-title":"Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase","volume":"142","author":"Niculescu","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0162-3109(99)00014-4","article-title":"Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells","volume":"42","author":"Niculescu","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yexmp.2003.10.002","article-title":"C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis","volume":"76","author":"Niculescu","year":"2004","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4049\/jimmunol.147.1.212","article-title":"Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9","volume":"147","author":"Papadimitriou","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0150","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF01069750","article-title":"Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury","volume":"424","author":"Papadimitriou","year":"1994","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0155","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.4049\/jimmunol.156.12.4892","article-title":"Sublytic complement attack induces cell cycle in oligodendrocytes","volume":"156","author":"Rus","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0162-3109(97)00063-5","article-title":"Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway","volume":"38","author":"Rus","year":"1997","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0165","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1073\/pnas.0501770102","article-title":"The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain","volume":"102","author":"Rus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/08916930600739605","article-title":"The complement system in central nervous system diseases","volume":"39","author":"Rus","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0175","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/339620a0","article-title":"Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement","volume":"339","author":"Scolding","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0180","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.4049\/jimmunol.163.11.6132","article-title":"Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation","volume":"163","author":"Soane","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0185","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.167.4.2305","article-title":"C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase\/Akt pathway","volume":"167","author":"Soane","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jnr.1155","article-title":"Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques","volume":"65","author":"Solanky","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000111893","article-title":"Expression and modulation of K+ currents in oligodendrocytes: possible role in myelinogenesis","volume":"11","author":"Soliven","year":"1989","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0200","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.410430409","article-title":"Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination","volume":"43","author":"Storch","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0205","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1056780","article-title":"Lack of replicative senescence in cultured rat oligodendrocyte precursor cells","volume":"291","author":"Tang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.137.2.459","article-title":"Differentiation and death of premyelinating oligodendrocytes in developing rodent brain","volume":"137","author":"Trapp","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/glia.20088","article-title":"Shaker-type potassium channel subunits differentially control oligodendrocyte progenitor proliferation","volume":"48","author":"Vautier","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.yexmp.2011.04.006_bb0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jneuroim.2006.04.014","article-title":"Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions","volume":"176","author":"Wilson","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.yexmp.2011.04.006_bb0225","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1096\/fj.02-0814fje","article-title":"The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop","volume":"17","author":"Zwaka","year":"2003","journal-title":"FASEB J."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480011000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480011000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T13:10:37Z","timestamp":1686057037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480011000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0014480011000360"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2011.04.006","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}